Concord Drugs Ltd — Insider Trading, 25-06-2026: Insider Trading / SAST

Concord Drugs Limited has closed its trading window effective July 1st for all insiders, including Directors and Designated Employees. This action is taken in preparation for the Board's consideration of the unaudited financial results for the quarter ending June. During this period, insiders and their immediate relatives are restricted from trading the company's securities. The trading window will reopen 48 hours after the financial results are publicly announced. This is a standard practice signaling that the company's quarterly performance update is upcoming.